News

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.
NEW CANAAN, CT / ACCESS Newswire / June 30, 2025 / Network-1 T, Inc. (NYSE:NTIP) announced today that it has initiated patent ...
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...
The European Commission has issued an informal guidance letter to provide antitrust guidance for the creation of a licensing negotiation group in the ...
The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...
Poised for Immediate Commercial Deployments and Licensing OpportunitiesCORNELIUS, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- ...
Also in Germany, two partners, from DLA Piper and Clifford Chance, have joined forces to form a litigation boutique in Munich ...
As scientific breakthroughs continue to transform medicine in 2025, companies across the biotech and pharmaceutical sectors ...
Apple must pay TOT Power Control, a Spanish patent owner, more than $110.7 million in damages for infringing a patent related ...
China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...